Beware the meta-analysis - clozapine and suicidal ideation

Schizophrenia Research

Volumn 86, Issue 1-3, 2006, Pages 331-332

  Haas, Steven J ^a,b   Dennekamp, Martine N ^c   Wolfe, Rory ^c   Vos, Theo ^d  

^a NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE;

DEMOGRAPHY; HUMAN; LETTER; MEDICAL LITERATURE; METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; META-ANALYSIS; META-ANALYSIS AS TOPIC; SCHIZOPHRENIA; SUICIDE;

EID: 33747407374     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.06.032     Document Type: Letter

References (10)

1. Chalmers I. Underreporting research is scientific misconduct. JAMA 263 10 (1990) 1405-1408
2. Ernst C.L., and Goldberg J.F. Antisuicide properties of psychotropic drugs: a critical review. Harv. Rev. Psychiatry 12 1 (2004) 14-41
3. Flather M.D., Farkouh M.E., Pogue J.M., and Yusuf S. Strengths and limitations of meta-analysis: larger studies may be more reliable. Control. Clin. Trials 18 6 (1997) 568-579 (discussion 661-6)
4. Glick I.D., Zaninelli R., Hsu C., Young F.K., Weiss L., Gunay I., and Kumar V. Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior. J. Clin. Psychiatry 65 5 (2004) 679-685
5. Hennen J., and Baldessarini R.J. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr. Res. 73 2-3 (2005) 139-145
6. Ioannidis J.P., and Lau J. Pooling research results: benefits and limitations of meta-analysis. Joint Comm. J. Qual. Improv. 25 9 (1999) 462-469
7. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., Bourgeois M., Chouinard G., Islam M.Z., Kane J., Krishnan R., Lindenmayer J.P., and Potkin S. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry 60 1 (2003) 82-91
8. Tandon R., and Fleischhacker W.W. Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment. Schizophr. Res. 79 2-3 (2005) 145-155
9. Thompson S.G., and Pocock S.J. Can meta-analyses be trusted?. Lancet 338 8775 (1991) 1127-1130
10. Tierney J.F., and Stewart L.A. Investigating patient exclusion bias in meta-analysis. Int. J. Epidemiol. 34 1 (2005) 79-87